Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $6.5000 (-0.76%) ($6.5000 - $6.5000) on Sat. Feb. 27, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.82% (three month average) | RSI | 31 | Latest Price | $6.5000(-0.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -1.9% a day on average for past five trading days. | Weekly Trend | AUTL declines -6.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting AUTL price | AUTL will decline at least -2.41% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.41% (StdDev 4.82%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-7.07(-208.77%) | Resistance Level | $7.29 | 5 Day Moving Average | $6.7(-2.99%) | 10 Day Moving Average | $6.95(-6.47%) | 20 Day Moving Average | $7.29(-10.84%) | To recent high | -45.3% | To recent low | 0% | Market Cap | $N/A | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |